Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001181431-13-007973

Options or other derivatives

  • SVP & Chief Financial Officer acquired 185,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nicholson John · SVP & Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-02-06 Grant or award : show line 1 in the form Stock Option +92,500 $8.80 2021-02-05 92,500 92,500 D
2013-02-06 Grant or award : show line 2 in the form Stock Option +92,500 $8.80 2021-02-05 92,500 92,500 D
Loading xslF345X03/rrd369532.xml…